Novo Nordisk News | Latest News

Novo Nordisk

 The Motley Fool05:42
 Scrip Pharma Intelligence19:40
 Proactive Investors (US)15:42
 Nasdaq14:57
 BNN Bloomberg11:27
 Fortune09:29
 Seeking Alpha17:02

Latest News

In the last hour

PMLiVE07:42

In the last 4 hours

The Motley Fool05:52

In the last 6 hours

Imperial College London04:07

Yesterday

MorningStar.com22:12 20-Jan-25

Zacks10:02 20-Jan-25

Fortune07:16 20-Jan-25

Clinical Trials Arena06:38 20-Jan-25

In the last 7 days

pharmaphorum07:21 19-Jan-25

The Financial Express22:01 18-Jan-25

The Motley Fool05:42 18-Jan-25

Apricitas Economics04:36 18-Jan-25

Scrip Pharma Intelligence19:40 17-Jan-25

Yahoo! US16:25 17-Jan-25

Proactive Investors (US)15:42 17-Jan-25

BioPharma Dive15:12 17-Jan-25

Nasdaq14:57 17-Jan-25

Yahoo! US14:34 17-Jan-25

NECN, New England12:47 17-Jan-25

Orange County Register12:37 17-Jan-25

Yahoo! UK & Ireland12:15 17-Jan-25

Fox News11:59 17-Jan-25

The Motley Fool11:39 17-Jan-25

Proactive Investors (US)11:28 17-Jan-25

BNN Bloomberg11:27 17-Jan-25

Washington Examiner10:56 17-Jan-25

Yahoo! US10:29 17-Jan-25

WHDH-TV, Massachusetts09:56 17-Jan-25

FiercePharma09:56 17-Jan-25

Yahoo! US09:48 17-Jan-25

Fortune09:29 17-Jan-25

Benzinga09:28 17-Jan-25

Quartz09:23 17-Jan-25

The Washington Times09:14 17-Jan-25

Yahoo! US09:07 17-Jan-25

TipRanks08:48 17-Jan-25

BioPharma Dive08:14 17-Jan-25

Bloomberg Law08:11 17-Jan-25

RTT News07:35 17-Jan-25

GlobeNewswire (Press Release)07:18 17-Jan-25

Seeking Alpha17:02 16-Jan-25

Yahoo! UK & Ireland14:31 16-Jan-25

PMLiVE07:34 16-Jan-25

Korea JoongAng Daily04:23 16-Jan-25

Korea JoongAng Daily23:27 15-Jan-25

Korea Biomedical Review21:46 15-Jan-25

Seeking Alpha12:28 15-Jan-25

Ground Truths11:36 15-Jan-25

24/7 Wall St.09:09 15-Jan-25

Quartz05:04 15-Jan-25

Law36022:26 14-Jan-25

Law36013:35 14-Jan-25

Nasdaq12:23 14-Jan-25

Business Wire (Press Release)12:14 14-Jan-25

The Motley Fool12:12 14-Jan-25

NewsMax11:12 14-Jan-25

Proactive Investors (UK)06:02 14-Jan-25

In the last month

Law36020:06 13-Jan-25

U.S. PIRG17:08 13-Jan-25

Barchart10:46 13-Jan-25

GlobeNewswire (Press Release)08:54 13-Jan-25

The New Republic19:00 12-Jan-25

Community Impact Newspaper14:26 10-Jan-25

Investors Chronicle07:29 10-Jan-25

MediaOutReach (Press Release)04:35 10-Jan-25

Invezz03:52 10-Jan-25

Mint01:51 10-Jan-25

Barchart21:25 9-Jan-25

Scrip Pharma Intelligence18:37 9-Jan-25

Yahoo! US16:29 9-Jan-25

Miami Herald12:58 9-Jan-25

Zacks09:35 9-Jan-25

Pharmaceutical Technology06:55 9-Jan-25

UKTN (UK Tech News)05:25 9-Jan-25

Pharmaceutical Technology05:23 9-Jan-25

MediaOutReach (Press Release)04:33 9-Jan-25

BNN Bloomberg02:34 9-Jan-25

BC Business Magazine20:56 8-Jan-25

Power Corridor18:56 8-Jan-25

Econbrowser (Weblog)18:30 8-Jan-25

Voxel Matters14:59 8-Jan-25

Genetic Engineering and Biotechnology News14:06 8-Jan-25

Yahoo! US13:08 8-Jan-25

News-Medical.Net13:00 8-Jan-25

Yahoo! US10:55 8-Jan-25

The Motley Fool10:34 8-Jan-25

Yahoo! UK & Ireland10:13 8-Jan-25

The Motley Fool09:53 8-Jan-25

Benzinga09:52 8-Jan-25

Benzinga09:12 8-Jan-25

pharmaphorum08:50 8-Jan-25

FierceBiotech08:07 8-Jan-25

Business Wire (Press Release)08:04 8-Jan-25

pharmaphorum07:08 8-Jan-25

GlobeNewswire (Press Release)06:33 8-Jan-25

Clinical Trials Arena04:48 8-Jan-25

Pharmaceutical Technology18:51 7-Jan-25

The Globalist12:00 7-Jan-25

FierceBiotech10:47 7-Jan-25

ENDPOINTS10:43 7-Jan-25

Benzinga08:47 7-Jan-25

TipRanks08:28 7-Jan-25

PR Newswire (Press Release)07:10 7-Jan-25

Seeking Alpha19:51 6-Jan-25

Yahoo! UK & Ireland13:01 6-Jan-25

Benzinga08:26 6-Jan-25

pharmaphorum05:57 6-Jan-25

Marketing Beat05:16 6-Jan-25

Scrip Pharma Intelligence05:02 6-Jan-25

The Motley Fool04:32 6-Jan-25

CLS Blue Sky00:56 6-Jan-25

The Motley Fool05:25 5-Jan-25

Yahoo! UK & Ireland14:09 4-Jan-25

The Motley Fool05:51 4-Jan-25

Morningstar11:38 3-Jan-25

Pharmaceutical Technology07:21 3-Jan-25

view more headlines

21 Jan 07:42

About our Novo Nordisk news

Latest news on Novo Nordisk, a global healthcare company focused on diabetes care, obesity treatment, and other serious chronic diseases. Get updates on Novo Nordisk's products, research, financial performance, and stock price.

Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark. Founded in 1923, the company has grown to become a global leader in diabetes care, with a strong presence in the fields of hemophilia, growth hormone therapy, and obesity treatment. Novo Nordisk's key products include insulin analogs like Tresiba and Levemir, GLP-1 receptor agonists such as Victoza and Ozempic, and obesity drugs like Saxenda and Wegovy.

Stay informed about the latest developments in Novo Nordisk's research and development pipeline, including updates on clinical trials, regulatory approvals, and new product launches. Our feed covers the company's ongoing efforts to innovate and improve treatments for diabetes, obesity, and other metabolic disorders, such as the development of oral semaglutide and the exploration of novel drug targets.

In addition to product news, our Novo Nordisk feed keeps you updated on the company's financial performance, including quarterly earnings reports, sales figures, and market share data. We also cover key events and announcements that may impact Novo Nordisk's stock price (NYSE: NVO), such as strategic partnerships, acquisitions, and leadership changes.

Beyond the business aspects, our feed highlights Novo Nordisk's commitment to corporate social responsibility and sustainability. From initiatives to improve access to diabetes care in developing countries to efforts to reduce the company's environmental footprint, we provide a comprehensive view of Novo Nordisk's impact on global health and society.

As the prevalence of diabetes and obesity continues to rise worldwide, Novo Nordisk plays a crucial role in addressing these global health challenges. Our 쮸떴눈첵 feed on Novo Nordisk brings you the most relevant and up-to-date information from reliable sources, helping you stay informed about this innovative and influential healthcare company.

쮸떴눈첵

Novo Nordisk

Latest News

About our Novo Nordisk news

Pharmaceuticals Top Stories

Business Top Stories